NCT01573624 - Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma | Biotech Hunter

Enrollment

421

Participants

Timeline

Start Date

April 3, 2012

Primary Completion Date

February 4, 2013

Study Completion Date

February 4, 2013

Conditions

Asthma

Interventions

DRUG

FF/GSK573719

100/15.6

DRUG

FF/GSK573719

100/31.25

DRUG

FF/GSK573719

100/62.5

DRUG

FF/GSK573719

100/125

DRUG

FF/GSK573719

100/250

DRUG

100

DRUG

FF/VI

100/25

Trial Locations (32)

4000

GSK Investigational Site, San Miguel de Tucumán

10330

GSK Investigational Site, Bangkok

10400

GSK Investigational Site, Bangkok

11000

GSK Investigational Site, Nonthaburi

29118

GSK Investigational Site, Orangeburg

29303

GSK Investigational Site, Spartanburg

40002

GSK Investigational Site, Khon Kaen

63141

GSK Investigational Site, St Louis

97504

GSK Investigational Site, Medford

123367

GSK Investigational Site, Moscow

141600

GSK Investigational Site, Klin

150003

GSK Investigational Site, Yaroslavl

194354

GSK Investigational Site, Saint Petersburg

194356

GSK Investigational Site, Saint Petersburg

420015

GSK Investigational Site, Kazan'

450071

GSK Investigational Site, Ufa

634001

GSK Investigational Site, Tomsk

634055

GSK Investigational Site, Tomsk

656038

GSK Investigational Site, Barnaul

2341131

GSK Investigational Site, Valparaíso

3460001

GSK Investigational Site, Talca

7500551

GSK Investigational Site, Santiago

7500800

GSK Investigational Site, Santiago

8207257

GSK Investigational Site, Puente Alto - Santiago

8380453

GSK Investigational Site, Santiago

8880465

GSK Investigational Site, Santiago

C1424BSF

GSK Investigational Site, Buenos Aires

C1425BEN

GSK Investigational Site, Buenos Aires

C1426ABP

GSK Investigational Site, Buenos Aires

M5500CCG

GSK Investigational Site, Mendoza

T4000DGF

GSK Investigational Site, San Miguel de Tucumán

115 280

GSK Investigational Site, Moscow